Mgr. Adriana Ladungová

Research specialist - PhD student, Michal Šmída Research Group

office: bldg. E35/142
Kamenice 753/5
625 00 Brno

Show on the map

phone:	+420 549 49 5875
e‑mail:

social and academic networks:

Basic information

Type

Total number of publications: 22

2024

ANALYSIS OF ALTERNATIVE THERAPEUTIC OPTIONS FOR ACUTE MYELOID LEUKEMIA PATIENTS RESISTANT TO VENETOCLAX BASED ON DRUG SCREENING AND EXPRESSION PROFILING

STYLIANOU Filio LADUNGOVÁ Adriana HÝL Jan BUŠA Daniel ČULEN Martin WEINBERGEROVÁ Barbora MAYER Jiří ŠMÍDA Michal

Conference abstract

Year: 2024, type: Conference abstract
EXPLORING VENETOCLAX RESISTANCE MECHANISMS IN AML CELLS THROUGH GENOME-WIDE CRISPR SCREENS AND DRUG PROFILING

LADUNGOVÁ Adriana STYLIANOU Filio PESCHELOVÁ Helena LODHI Yusuf DOSTÁLOVÁ Lenka GOTTUMUKKALA Narendra Varma ŠMÍDA Michal

Conference abstract

Year: 2024, type: Conference abstract
Novel casein kinase 1 alpha inhibitors for the treatment of resistant AML and solid tumors

JANOVSKÁ Pavlína RADASZKIEWICZ Tomasz Witold PROCHAZKOVA P PRIŠTICOVÁ Ingrid PLEŠINGEROVÁ Hana ČULEN Martin ŠMÍDA Michal BUŠA Daniel LADUNGOVÁ Adriana MAIER Lukáš HAVEL Štěpán MAYER Jiří SCHEER A PARUCH Kamil BRYJA Vítězslav

Conference abstract

Year: 2024, type: Conference abstract

2023

CRISPR/Cas9 technology as a useful tool in the study of chornic lymphocytic leukemia.

PESCHELOVÁ Helena MANČÍKOVÁ Veronika DOSTÁLOVÁ Lenka LADUNGOVÁ Adriana ŠKRNOVÁ Dominika HEJRET Václav ŠMÍDA Michal

Conference abstract

Year: 2023, type: Conference abstract
CRISPR/Cas9 technology as a useful tool in the study of chronic lymphocytic leukemia.

PESCHELOVÁ Helena KOZLOVÁ Veronika MANČÍKOVÁ Veronika DOSTÁLOVÁ Lenka LADUNGOVÁ Adriana ŠKRNOVÁ Dominika HEJRET Václav ŠMÍDA Michal

Conference abstract

Year: 2023, type: Conference abstract
Exploring the mechanisms of Venetoclax resistence via drug screening and genome-wide CRISPR screening.

LADUNGOVÁ Adriana PESCHELOVÁ Helena DOSTÁLOVÁ Lenka LODHI Yusuf GOTTUMUKKALA Narendra Varma MAYER Jiří ŠMÍDA Michal

Conference abstract

Year: 2023, type: Conference abstract
Chasing the epigenetic landscape to enhance CAR-T cell activity py preventing CD19 antigen escape in relapsed models.

GOTTUMUKKALA Narendra Varma LEDEREROVÁ Aneta DOSTÁLOVÁ Lenka LADUNGOVÁ Adriana LODHI Yusuf ŠMÍDA Michal

Conference abstract

Year: 2023, type: Conference abstract

2022

. Drug repurposing for venetoclax-resistant acute myeloid leukemia.

LADUNGOVÁ Adriana BUŠA Daniel LODHI Yusuf HÝL Jan ČULEN Martin ŠMÍDA Michal

Conference abstract

Year: 2022, type: Conference abstract
Combined drug and CRISPR/CAS9 screening reveals specific targets for SF3B1- and NOTCH1- mutated CLL cells.

DOSTÁLOVÁ Lenka LADUNGOVÁ Adriana ŠKRNOVÁ Dominika GOTTUMUKKALA Narendra Varma LODHI Yusuf ŠMÍDA Michal

Conference abstract

Year: 2022, type: Conference abstract
Genome-wide Screening Optimizations and High-throughput Compound Screening to Identify Novel Treatment Options in Venetoclax-resistant AML

LODHI Yusuf LADUNGOVÁ Adriana BUŠA Daniel PESCHELOVÁ Helena ČULEN Martin ŠMÍDA Michal

Conference abstract

Year: 2022, type: Conference abstract